CoronaCentral

  • Dashboard

  • Trending

  • Epidemiology
    Forecasting & Modelling
    Infection Reports
    Transmission
    Contact Tracing
    Prevalence
    Prevention
    Surveillance
  • Clinical
    Clinical Reports
    Risk Factors
    Long Haul
    Pediatrics
    Medical Specialties
    Recommendations
    Imaging
    Diagnostics
    Healthcare Workers
  • Biology
    Molecular Biology
    Immunology
    Model Systems & Tools
    Non-human
  • Treatment
    Therapeutics
    Drug Targets
    Vaccines
    Clinical Trials
    Medical Devices
  • Psychology
  • Policy
    Health Policy
    Communication
    Inequality
    Education
  • Other Articles
    Reviews
    Meta-analysis
    Comments & Editorials
    CDC Weekly Reports
    Book Chapters
    News
    Non-medical
    Retractions
    Misinformation

  • Mentions
    Drugs
    Genes or Proteins
    Genetic Variation
    Locations
    Medical Specialties
    Prevention Methods
    Risk Factors
    Species
    Symptoms
    Test Types
    Transmission Types
    Vaccine Types
    Viral Lineages

  • FAQs
  • Feedback

Immunology

Share
Research studying the interactions of the virus and the immune system
Published and Preprint Papers
Filter
Title
Altmetric
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.

Vaccinated and unvaccinated individuals have similar viral loads in communities with a high prevalence of the SARS-CoV-2 delta variant

Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

The SARS-CoV-2 Delta variant is poised to acquire complete resistance to wild-type spike vaccines

Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals.

Immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection.

Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines.

SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.

Class switch toward noninflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination.

Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19.

Project funded by the Chan Zuckerberg Biohub and NLM grant LM05652